Cpap cutout.jpg
Location data
Loading map...


Medical equipment data
Health topic Child mortality
Health classification Treatment
Project data
Status Commercialized
Download Open Know How Manifest
Page data
Part of Global Health Medical Device Compendium
Type Medical equipment, Project
SDG Sustainable Development Goals SDG03 Good health and well-being
Published 2013
License CC-BY-SA-3.0
Language English (en)
Impact Number of views to this page. Views by admins and bots are not counted. Multiple views during the same session are counted as one. 1,354


Problem being addressed[edit | edit source]

1.8 million children under five died from respiratory complications in 2011, most in low-income countries. Continuous Positive Airway Pressure (CPAP) is a treatment for respiratory distress that could save the lives of many infants and preterm babies. However, the cost of conventional CPAP is prohibitive as it requires high, continuous flows of oxygen and air, resulting in high running costs that are unsustainable in a developing country. As a result CPAP is rarely available in developing countries, even in lifesaving situations.

Detailed description of the solution[edit | edit source]

The Diamedica Baby CPAP machine has been designed for use in areas with limited resources. It is driven by an oxygen concentrator, thus eliminating the need for large quantites of expensive compressed gases. It provides controllable safe bubble CPAP with minimal running costs, for use with preterm babies, neonates and infants.

Designed by[edit | edit source]

  • Designed by: Diamedica (UK) Ltd, Grange Hill Industrial Estate, Bratton Fleming, Devon EX31 4UH, United Kingdom http://www.diamedica.co.uk
  • Manufacturer (if different):
  • Manufacturer location: United Kingdom

When and where it was tested/implemented[edit | edit source]

Presently in use in ten countries: Afghanistan, Congo, Ethiopia, Kenya, Libya, Malawi, Papua New Guinea, Sierra Leone, Solomon Islands, Uganda

Funding Source[edit | edit source]

References[edit | edit source]

Peer-reviewed publication[edit | edit source]

Other internally generated reports[edit | edit source]

Externally generated reports[edit | edit source]

IP and copyright[edit | edit source]

Approval by regulatory bodies or standards boards[edit | edit source]